Celldex Therapeutics - CLDX Company Short-Term Debt

Graphic logo of Celldex Therapeutics (CLDX)

Celldex Therapeutics (CLDX) develops unique antibodies to combat skin inflammation, leveraging patents for mast cell inhibitors. In collaboration with medical centers, the company is implementing precision therapy for cancer and immune dysfunction. The stock price trend on GURU.Markets demonstrates the 0.01 indicator. Business stability is guaranteed by a strong team of scientists, securely retained through a system of stock options.

CLDX (Celldex Therapeutics Inc) Company Short-Term Debts history from 07/04/2022 to 10/28/2026

Celldex Corp - analytical breakdowns and key metrics (CLDX)

- price and consensus price forecast:
Price Chart Celldex Therapeutics, Inc.|CLDX - Fair Value Consensus
- market capitalization data:
Market Value Celldex Therapeutics, Inc.|CLDX - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Celldex Therapeutics|CLDX - Book Capitalization|Market Cap to Net Assets Ratio celldex.com|CLDX - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Celldex Therapeutics|CLDX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Celldex Therapeutics|CLDX - Company Total Debt|Debt to Book Capitalization Ratio Celldex Therapeutics, Inc.|CLDX - Company Long-Term Liabilities|Company Current Liabilities Celldex Therapeutics
Fundamental company valuation:Celldex Therapeutics, Inc. - CLDX
Product sample of Celldex Therapeutics

This metric aggregates all Celldex Therapeutics (CLDX) liabilities with a maturity of up to one year. The metric reflects the current liquidity burden and the firm's ability to service operational loans. For the biotechnology sector with a diversified antibody portfolio, such funds are critical when conducting multi-profile clinical trials. Reducing debt strengthens the asset's financial stability. By analyzing the company's short-term debt dynamics, an investor assesses the balance between default risk and capital efficiency.

Competitor analysis

Company Short-Term Debt argenx (ARGX)|BNTX: Company Short-Term Loans and Borrowings|ABVX (Abivax) - Company Short-Term Debt|ADMA Corp (ADMA) - Company Current Liabilities|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com (IMVT)|Kiniksa (KNSA) - Company Current Liabilities|Company Short-Term Loans and Borrowings Grifols SA (GRFS)|Company Short-Term Debts ADPT|Aurinia Corp - Short-Term Debt Volume|BCRX: Company Short-Term Debt|VERA: Company Current Liabilities|DNTH (Dianthus Therapeutics, Inc.) - Company Short-Term Debt|Company Current Liabilities Pharvaris NV|ABCL (AbCellera Biologics) - Company Current Liabilities|Company Short-Term Debts TRML|Company Short-Term Debt Precigen, Inc. PGEN|Company Short-Term Indebtedness pharming.com (PHAR)|NKTR: Company Short-Term Debts|Short-Term Debt Upstream Bio, Inc. UPB|ZBIO: Company Short-Term Debts|IMNM - Company Current Liabilities|Company Short-Term Debts GOSS|KALV (kalvista.com) - Short-Term Debt|Company Short-Term Debt Septerna|Company Short-Term Debt PVLA|Company Short-Term Debt Savara Corp (SVRA)|Company Short-Term Debt Rigel Corp (RIGL)|ANAB - Company Short-Term Debts|Company Short-Term Indebtedness astriatx.com ATXS|ENGN (enGene) - Company Short-Term Debts|rapt.com (RAPT) - Short-Term Debt|Company Current Liabilities aerovatetx.com|Company Short-Term Indebtedness Aclaris Therapeutics, Inc|KYTX - Company Current Liabilities|Company Short-Term Loans and Borrowings tizianalifesciences.com (TLSA)|Company Current Liabilities Cabaletta Bio|Amount of Current Liabilities Ventyx Biosciences Inc. (VTYX)|Company Short-Term Debts Theratechnologies Inc|Company Short-Term Loans and Borrowings Avalo Therapeutics Inc AVTX|ELDN (Eledon Pharmaceuticals) - Company Short-Term Debts|AGEN: Short-Term Debt|Company Short-Term Debt Climb Bio CLYM|zurabio.com (ZURA) - Company Short-Term Loans and Borrowings|ATYR (aTyr) - Company Short-Term Debts|Company Short-Term Debts ADAG|IMA - Company Short-Term Debt|Current Liabilities shattucklabs.com (STTK)|EQ: Company Short-Term Debts|CNTB - Short-Term Debt|Immunic Inc - Company Current Liabilities|Atara Biotherapeutics (ATRA) - Company Short-Term Debts|IFRX - Company Current Liabilities|x4pharma.com (XFOR) - Amount of Current Liabilities|ACET: Company Short-Term Debts|Short-Term Debt Volume Celularity Corp|Company Short-Term Debts INMB (INmune Bio Corp)|Company Current Liabilities BRNS (Barinthus Biotherapeutics Corp)|Company Short-Term Debt KZR|Short-Term Debt Volume sabbiotherapeutics.com SABS|AKTX: Company Short-Term Debts|ENLV: Company Current Liabilities|q32bio.com (QTTB) - Company Short-Term Debt|GeoVax Corp (GOVX) - Company Short-Term Debt|Company Short-Term Debts Edesa Biotech, Inc. (EDSA)|Company Short-Term Indebtedness ibioinc.com (IBIO)|Company Current Liabilities Carisma Therapeutics CARM|Company Short-Term Indebtedness XTLB (XTL Biopharmaceuticals Ltd)|Bolt Biotherapeutics, Inc. (BOLT) - Company Short-Term Debt|Current Liabilities HCW Biologics, Inc. HCWB|Company Short-Term Debts Aptevo (APVO)|AIM - Company Short-Term Loans and Borrowings|ADTX: Company Short-Term Debts|GRI (GRI Bio Inc) - Company Short-Term Debts|XRTX - Company Short-Term Debt|Company Short-Term Loans and Borrowings HIND|Company Short-Term Debt REVB (Revelation Biosciences)|Company Current Liabilities indaptusrx.com (INDP)|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|CALI - Company Short-Term Debts|Company Current Liabilities Affimed Therapeutics (AFMD)|ALLK - Company Short-Term Loans and Borrowings|hookipapharma.com - Company Short-Term Debts|IGMS (IGM Biosciences) - Short-Term Debt Volume|Company Short-Term Debt ITOS|Company Current Liabilities OCEA|Company Short-Term Debt TCBP (TC BioPharm (Holdings) PLC)|Company Current Liabilities Third Harmonic Bio Inc THRD